Veradermics Total Liabilities & Equity increased by 160.4% to $397.36M in Q1 2026 compared to the prior quarter.
An increase typically reflects overall balance sheet growth or expansion of the company's asset base, while a decrease may indicate divestitures or debt repayment.
This represents the sum of all claims against a company's assets, combining obligations to external creditors and the re...
This is a standard accounting identity used across all industries to verify that assets equal the sum of liabilities and equity.
total_liabilities_and_equity| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $152.62M | $397.36M |
| QoQ Change | — | +160.4% |